Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATX-101 for mild or extreme submental fat
NCT02035267Phase 3Completed
- Sponsor
- Kythera Biopharmaceuticals
- Start
- Jan 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium deoxycholate in submental fullness, sponsored by Kythera Biopharmaceuticals. Started Jan 2014; status: completed.
02
Drugs
sodium deoxycholate
03
Conditions
submental fullness
Beyond the preview
Go deeper on NCT02035267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02035267.